Crohn’s Disease and Ulcerative Colitis affects more than a million people including their families in Southern California ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

Johnson & Johnson (J&J) has shared positive long-term results from a phase 3 trial of its dual-acting IL-23 inhibitor Tremfya ...

The research also predicts inflammatory bowel disease diagnoses will likely double in Aotearoa in the next 20 years.

To evaluate the therapeutic value of mirikizumab in IBD, researchers conducted a systematic review and meta-analysis of ...

Women with the autoimmune diseases rheumatoid arthritis, lupus or systemic sclerosis may have a higher rate of death related to cardiovascular disease than men with the autoimmune diseases, according ...

CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading ...

For an accessible version of this Press Release, please visit On track for 30% operating profit margin by 2027 in line with ...

A groundbreaking international study, with involvement from the University of Otago, Christchurch, has identified four distinct stages associated with ...

NET LOSS FORECAST: Takeda is expected to post a net loss of 81.7 billion yen, equivalent to $573.7 million, for the three months ended March, according to a Visible Alpha poll of analysts. That ...

The possibility that it was shingles never crossed her mind. After all, she’d always heard it was an illness that mainly ...